# Johnson & Johnson vs Eli Lilly: stocks compared

URL: https://funkfolio.com/compare/jnj-vs-lly

> Johnson & Johnson ($670.9B, P/E 42.3) and Eli Lilly ($1.26T, P/E 45.9) compared: size, valuation, margins, debt, cash and price change.

---

## Johnson & Johnson vs Eli Lilly

Johnson & Johnson (JNJ), health care, and Eli Lilly (LLY), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Eli Lilly is worth $1.26T on the stock market and Johnson & Johnson $670.9B: Eli Lilly is valued at 88% more. Johnson & Johnson trades at 42.3 times earnings and Eli Lilly at 45.9. Over the past year Johnson & Johnson's share price has moved +41.3% and Eli Lilly's +39.0%.

### Key facts

- **Johnson & Johnson market value:** $670.9B
- **Eli Lilly market value:** $1.26T
- **Johnson & Johnson P/E:** 42.3
- **Eli Lilly P/E:** 45.9
- **Johnson & Johnson revenue:** $94.2B FY to 2025-12-28
- **Eli Lilly revenue:** $65.2B FY to 2025-12-31
- **Superinvestors holding both:** 12

Market values as of 18 Nov 2026, 06:57 UTC.

Johnson & Johnson vs Eli Lilly: every measure side by side

| Measure | Johnson & Johnson | Eli Lilly |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-28 | 2025-12-31 |
| Size |  |  |
| Market cap | $670.9B lower | $1.26T higher |
| Revenue | $94.2B higher | $65.2B lower |
| Earnings | $26.8B higher | $20.6B lower |
| Employees | 138,200 higher | 50,000 lower |
| Total assets | $199.2B higher | $112.5B lower |
| Valuation |  |  |
| P/E | 42.3 lower | 45.9 higher |
| P/S | 7.1 lower | 19.3 higher |
| P/B | 8.2 lower | 31.3 higher |
| Dividend yield | 1.87% higher | 0.47% lower |
| Profitability |  |  |
| Operating margin | — | — |
| Balance sheet |  |  |
| Net assets | $81.5B higher | $26.5B lower |
| Total liabilities | $117.7B higher | $85.9B lower |
| Total debt | $47.9B higher | $42.5B lower |
| Cash on hand | $19.7B higher | $7.3B lower |
| Price change |  |  |
| Today | -1.36% lower | -1.13% higher |
| 1 year | +41.3% higher | +39.0% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Johnson & Johnson 139.6, Eli Lilly 138.5.

- Johnson & Johnson (JNJ)
- Eli Lilly (LLY)

Johnson & Johnson and Eli Lilly share prices over one year, rebased to 100: Johnson & Johnson ends at 139.6, Eli Lilly at 138.5.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | JNJ | LLY |
| --- | --- | --- |
| Nov 28, 2025 | 103.7 | 105.3 |
| Dec 31, 2025 | 103.7 | 105.2 |
| Jan 30, 2026 | 113.9 | 101.5 |
| Feb 27, 2026 | 124.5 | 103.0 |
| Mar 31, 2026 | 122.5 | 90.0 |
| Apr 30, 2026 | 115.2 | 91.5 |
| May 29, 2026 | 112.9 | 108.2 |
| Jun 30, 2026 | 127.3 | 117.4 |
| Jul 31, 2026 | 128.4 | 112.4 |
| Aug 31, 2026 | 133.2 | 113.2 |
| Sep 30, 2026 | 132.6 | 113.3 |
| Oct 30, 2026 | 136.9 | 138.7 |
| Nov 17, 2026 | 139.6 | 138.5 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (12)

- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 4.0% / 1.9%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 1.1% / 1.8%
- [Mairs & Power team](https://funkfolio.com/gurus/mairs-and-power) 0.9% / 3.4%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.7% / 0.4%
- [Cliff Asness](https://funkfolio.com/gurus/cliff-asness) 0.3% / 0.4%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.2% / 0.7%
- [Mario Gabelli](https://funkfolio.com/gurus/mario-gabelli) 0.2% / 0.3%
- [George Soros](https://funkfolio.com/gurus/george-soros) 0.1% / 0.4%
- [Jensen team](https://funkfolio.com/gurus/jensen-investment) 0.1% / 4.0%
- [Murray Stahl](https://funkfolio.com/gurus/murray-stahl) 0.1% / 0.1%
- [Rajiv Jain](https://funkfolio.com/gurus/rajiv-jain) &lt;0.1% / 1.6%
- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) &lt;0.1% / &lt;0.1%

#### Johnson & Johnson only (11)

- [Tweedy, Browne team](https://funkfolio.com/gurus/tweedy-browne) 4.1%
- [Stephen Yacktman](https://funkfolio.com/gurus/stephen-yacktman) 4.0%
- [Mark Boyar](https://funkfolio.com/gurus/mark-boyar) 2.6%
- [Tom Gayner](https://funkfolio.com/gurus/tom-gayner) 1.3%
- [Fred DiSanto](https://funkfolio.com/gurus/fred-disanto) 1.1%
- [Andrew Spokes](https://funkfolio.com/gurus/farallon) 0.7%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 0.3%
- [John Rogers](https://funkfolio.com/gurus/john-rogers) 0.1%
- [Christopher Bloomstran](https://funkfolio.com/gurus/christopher-bloomstran) &lt;0.1%
- [Howard Gleicher](https://funkfolio.com/gurus/howard-gleicher) &lt;0.1%
- [Thomas Russo](https://funkfolio.com/gurus/thomas-russo) &lt;0.1%

#### Eli Lilly only (16)

- [Primecap team](https://funkfolio.com/gurus/primecap) 6.5%
- [Polen Capital team](https://funkfolio.com/gurus/polen-capital) 4.6%
- [Larry Robbins](https://funkfolio.com/gurus/larry-robbins) 1.4%
- [Cathie Wood](https://funkfolio.com/gurus/cathie-wood) 0.7%
- [Jeffrey Altman](https://funkfolio.com/gurus/jeffrey-altman) 0.6%
- [Temasek](https://funkfolio.com/gurus/temasek) 0.5%
- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 0.5%
- [David Shaw (founder)](https://funkfolio.com/gurus/david-shaw) 0.4%
- [Stanley Druckenmiller](https://funkfolio.com/gurus/stanley-druckenmiller) 0.3%
- [John Overdeck and David Siegel (founders)](https://funkfolio.com/gurus/two-sigma) 0.3%
- [Frank Sands](https://funkfolio.com/gurus/frank-sands) 0.2%
- [Ron Baron](https://funkfolio.com/gurus/ron-baron) 0.2%
- [Paul Tudor Jones](https://funkfolio.com/gurus/paul-tudor-jones) 0.2%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.1%
- [Rob Citrone](https://funkfolio.com/gurus/rob-citrone) 0.1%
- [Bill Nygren](https://funkfolio.com/gurus/bill-nygren) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Johnson & Johnson / Eli Lilly). [Who owns JNJ](https://funkfolio.com/stock/JNJ/superinvestors) · [Who owns LLY](https://funkfolio.com/stock/LLY/superinvestors)

### More on Johnson & Johnson

- [Johnson & Johnson (JNJ) stock page](https://funkfolio.com/stock/JNJ)
- [Johnson & Johnson market cap](https://funkfolio.com/stock/JNJ/market-cap)
- [Johnson & Johnson revenue](https://funkfolio.com/stock/JNJ/revenue)
- [Johnson & Johnson P/E ratio](https://funkfolio.com/stock/JNJ/pe-ratio)
- [Johnson & Johnson operating margin](https://funkfolio.com/stock/JNJ/operating-margin)
- [Johnson & Johnson total debt](https://funkfolio.com/stock/JNJ/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Eli Lilly

- [Eli Lilly (LLY) stock page](https://funkfolio.com/stock/LLY)
- [Eli Lilly market cap](https://funkfolio.com/stock/LLY/market-cap)
- [Eli Lilly revenue](https://funkfolio.com/stock/LLY/revenue)
- [Eli Lilly P/E ratio](https://funkfolio.com/stock/LLY/pe-ratio)
- [Eli Lilly operating margin](https://funkfolio.com/stock/LLY/operating-margin)
- [Eli Lilly total debt](https://funkfolio.com/stock/LLY/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Johnson & Johnson against its closest peers

- [Johnson & Johnson vs AbbVie](https://funkfolio.com/compare/abbv-vs-jnj)
- [Johnson & Johnson vs Merck & Co](https://funkfolio.com/compare/jnj-vs-mrk)
- [Johnson & Johnson vs UnitedHealth Group](https://funkfolio.com/compare/jnj-vs-unh)

#### Eli Lilly against its closest peers

- [Eli Lilly vs AbbVie](https://funkfolio.com/compare/abbv-vs-lly)
- [Eli Lilly vs Merck & Co](https://funkfolio.com/compare/lly-vs-mrk)
- [Eli Lilly vs UnitedHealth Group](https://funkfolio.com/compare/lly-vs-unh)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Johnson & Johnson or Eli Lilly?**

By market value, Eli Lilly is the larger: $1.26T against $670.9B for Johnson & Johnson. By revenue in its latest fiscal year, Johnson & Johnson is the larger: $94.2B against $65.2B for Eli Lilly.

**Which has the higher P/E ratio?**

Eli Lilly: 45.9, against 42.3 for Johnson & Johnson. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher dividend yield?**

Johnson & Johnson: 1.87%, against 0.47% for Eli Lilly. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

Johnson & Johnson: $47.9B, against $42.5B for Eli Lilly. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Johnson & Johnson and Eli Lilly?**

In their latest 13F filings, Jeremy Grantham (co-founder), Ken Fisher, Mairs & Power team, Ray Dalio (founder), Cliff Asness, Ken Griffin, Mario Gabelli, George Soros, Jensen team, Murray Stahl, Rajiv Jain and Dodge & Cox team hold both.

### Cite this page

Funkfolio, “Johnson & Johnson vs Eli Lilly”, data as of 18 November 2026. https://funkfolio.com/compare/jnj-vs-lly

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
